This is an accepted manuscript of an article published by Wiley in British Journal of Haematology, available online on 05/11/2020 at: https://doi.org/10.1111/bjh.17136 The accepted version of the publication may differ from the final published version
Background: Several small studies on patients with COVID-19 and haematological malignancies are avai...
Objective: Patients with cancer are considered highly vulnerable to the COVID-19 disease. However, t...
OBJECTIVE: Hematologic cancer patients with Coronavirus Disease 2019 (COVID-19) tend to have a more ...
�� 2021 The Authors. Published by Hilaris. This is an open access article available under a Creative...
Objective: In the present study, we are reporting the clinical profile; and outcomes of COVID-19 in ...
Patients with haematological malignancies have a high risk of severe infection and death from SARS-C...
Background: Patients with cancer are considered highly vulnerable to the recent coronavirus disease ...
Patients with hematological malignancies (HM) are at high risk of mortality from SARS-CoV-2 disease ...
The COVID-19 pandemic has been a disruptive event for cancer patients, especially those with haemato...
This is an accepted manuscript of an article published by Wiley in European Journal of Haematology o...
Infection with the novel coronavirus SARS‐CoV‐2 virus resulting in an acute respiratory disease (COV...
Background: Patients with hematological malignancies (HM) are at high risk of mortality from SARS-Co...
Background: Several small studies on patients with COVID-19 and haematological malignancies are avai...
Objective: Patients with cancer are considered highly vulnerable to the COVID-19 disease. However, t...
OBJECTIVE: Hematologic cancer patients with Coronavirus Disease 2019 (COVID-19) tend to have a more ...
�� 2021 The Authors. Published by Hilaris. This is an open access article available under a Creative...
Objective: In the present study, we are reporting the clinical profile; and outcomes of COVID-19 in ...
Patients with haematological malignancies have a high risk of severe infection and death from SARS-C...
Background: Patients with cancer are considered highly vulnerable to the recent coronavirus disease ...
Patients with hematological malignancies (HM) are at high risk of mortality from SARS-CoV-2 disease ...
The COVID-19 pandemic has been a disruptive event for cancer patients, especially those with haemato...
This is an accepted manuscript of an article published by Wiley in European Journal of Haematology o...
Infection with the novel coronavirus SARS‐CoV‐2 virus resulting in an acute respiratory disease (COV...
Background: Patients with hematological malignancies (HM) are at high risk of mortality from SARS-Co...
Background: Several small studies on patients with COVID-19 and haematological malignancies are avai...
Objective: Patients with cancer are considered highly vulnerable to the COVID-19 disease. However, t...
OBJECTIVE: Hematologic cancer patients with Coronavirus Disease 2019 (COVID-19) tend to have a more ...